THC Farmaceuticals, Inc.
CBDG
$0.013
-$0.0011-7.80%
OTC PK
| 06/30/2015 | 03/31/2015 | 12/31/2014 | 09/30/2014 | 06/30/2014 | |
|---|---|---|---|---|---|
| Revenue | -2.12% | -3.16% | -9.31% | -11.98% | -18.53% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -2.12% | -3.16% | -9.31% | -11.98% | -18.53% |
| Cost of Revenue | 2.90% | -18.95% | -36.90% | -26.79% | -17.86% |
| Gross Profit | -15.69% | 62.16% | 119.44% | 38.78% | -20.31% |
| SG&A Expenses | 197.58% | 71.77% | 11.57% | 28.63% | -30.34% |
| Depreciation & Amortization | 28.57% | 12.50% | -30.00% | -36.36% | -41.67% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 125.70% | 36.19% | -8.83% | 4.61% | -26.68% |
| Operating Income | -242.44% | -68.78% | 8.76% | -22.34% | 32.79% |
| Income Before Tax | -173.96% | -49.82% | 5.66% | -28.45% | 22.06% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -173.96% | -49.82% | 5.66% | -28.45% | 22.06% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -173.96% | -49.82% | 5.66% | -28.45% | 22.06% |
| EBIT | -242.44% | -68.78% | 8.76% | -22.34% | 32.79% |
| EBITDA | -251.52% | -72.30% | 7.25% | -25.81% | 32.42% |
| EPS Basic | -92.86% | -20.69% | 20.00% | -22.22% | 26.32% |
| Normalized Basic EPS | -83.33% | -10.53% | 21.05% | -23.53% | 25.00% |
| EPS Diluted | -92.86% | -20.69% | 20.00% | -22.22% | 26.32% |
| Normalized Diluted EPS | -83.33% | -10.53% | 21.05% | -23.53% | 25.00% |
| Average Basic Shares Outstanding | 21.57% | 7.17% | 25.11% | 16.74% | 16.74% |
| Average Diluted Shares Outstanding | 21.57% | 7.17% | 25.11% | 16.74% | 16.74% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |